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Abstract
IMPORTANCE Sex differences in genetic associations with human longevity remain largely
unknown; investigations on this topic are important for individualized health care.
OBJECTIVE To explore sex differences in genetic associations with longevity.
DESIGN, SETTING, ANDPARTICIPANTS This population-based case-control study used
sex-specific genome-wide association study and polygenic risk score (PRS) analyses to examine sex
differences in genetic associations with longevity. Five hundred sixty-four male and 1614 female
participants older than 100 years were compared with a control group of 773male and 1526 female
individuals aged 40 to 64 years. All were Chinese Longitudinal Healthy Longevity Study participants
with Han ethnicity who were recruited in 1998 and 2008 to 2014.
MAINOUTCOMES ANDMEASURES Sex-specific loci and pathways associated with longevity and
PRSmeasures of joint effects of sex-specific loci.
RESULTS Elevenmale-specific and 11 female-specific longevity loci (P < 10−5) and 35male-specific
and 25 female-specific longevity loci (10−5  P < 10−4) were identified. Each of these loci’s
associations with longevity were replicated in north and south regions of China in one sex but were
not significant in the other sex (P = .13-.97), and loci-sex interaction effects were significant (P < .05).
The associations of loci rs60210535 of the LINC00871 genewith longevity were replicated in Chinese
women (P = 9.0 × 10−5) and US women (P = 4.6 × 10−5) but not significant in Chinese and USmen.
The associations of the loci rs2622624 of the ABCG2 gene were replicated in Chinese women
(P = 6.8 × 10−5) and European women (P = .003) but not significant in both Chinese and European
men. Eleven male-specific pathways (inflammation and immunity genes) and 34 female-specific
pathways (tryptophanmetabolism and PGC-1α induced) were significantly associated with longevity
(P < .005; false discovery rate < 0.05). The PRS analyses demonstrated that sex-specific associations
with longevity of the 4 exclusive groups of 11 male-specific and 11 female-specific loci (P < 10−5) and
35male-specific and 25 female-specific loci (10−5 P < 10−4) were jointly replicated across north and
south discovery and target samples. Analyses using the combined data set of north and south
showed that these 4 groups of sex-specific loci were jointly and significantly associated with
longevity in one sex (P = 2.9 × 10−70 to 1.3 × 10−39) but not jointly significant in the other sex (P = .11
to .70), while interaction effects between PRS and sex were significant (P = 4.8 × 10−50 to
1.2 × 10−16).
CONCLUSIONANDRELEVANCE The sex differences in genetic associations with longevity are
remarkable, but have been overlooked by previously published genome-wide association studies on
longevity. This study contributes to filling this research gap and provides a scientific basis for further
(continued)
Key Points
Question Are there sex differences in
genetic associations with longevity?
Findings In this case-control study of
2178 cases and 2299 controls who were
Chinesewith Han ethnicity, sex-specific
genome-wide association study and
sex-specific polygenic risk score
analyses on longevity showed
substantial and significant differences in
genetic associations with longevity
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genome-wide association studies on
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Abstract (continued)
investigating effects of sex-specific genetic variants and their interactions with environment on
healthy aging, whichmay substantially contribute to more effective and targeted individualized
health care for male and female elderly individuals.
JAMA Network Open. 2018;1(4):e181670.
Corrected on September 21, 2018. doi:10.1001/jamanetworkopen.2018.1670
Introduction
Centenarian genomesmay harbor genetic variants associated with longevity and health,1-5
supported by the fact that the proportion of genetic variants positively (or negatively) associated
with longevity and health is significantly higher (or lower) among centenarians compared with
middle-aged controls. This is because those who carry the longevity-favoring genetic variants have a
better chance of surviving to age 100 years or older, while thosewith less favorable genetic variants
may not reach 100 years. This relationship has been demonstrated empirically1-6 and proven
mathematically.6 Hence, all of the genome-wide association studies (GWAS) on longevity use
centenarians (and/or those aged90 years or85 years) as cases and younger adults as controls2-5
(eAppendix section S1 in the Supplement).
The extant literature indicates that associations of some genetic variants with health outcomes
differ significantly betweenmen andwomen.7-9 A recent study using the phenotype of parental age
at death as an outcome variable indicated that different genes may be associated with longevity in
men andwomen.10 However, sex differences have been overlooked in all previously published GWAS
on longevity that usedmale and female combined data sets adjusted for sex as a covariate.2-5 A few
GWAS of longevity conducted sex-specific analyses on the significant loci that were replicated in the
combinedmale and female discovery and evaluation stages, but none of those studies found that
their replicated loci had significant sex differences in the association with longevity.2-5 This is
because, statistically, if the tested variable is significant in one sex but not significant in the other sex,
it cannot be significant and replicated in the combined data sets, as the results of 2 sexes offset each
other in a combined data set of male and female results, while the sample size of either one of the
sexes is usually not small enough to leave the overall results unaffected.11 In other words, all
previously published GWAS on longevity identified sex-independent genetic variants, but the sex
differences have been overlooked. The present study aims to fill this research gap and contribute to
a better understanding of sex differences in genetic associations with longevity.
Methods
We analyzed Chinese Longitudinal Healthy Longevity Study (CLHLS) data sets of GWAS on longevity,
with 564male and 1614 female participants aged 100 years or older (mean [SD] age, 102.7 [3.49]
years) as cases and 773male and 1526 female participants aged 40 to 64 years (mean [SD] age, 48.4
[7.44] years) as controls. All were Chinese with Han ethnicity (eAppendix sections S2-S3 in the
Supplement). The CLHLS GWAS has the largest sample size of centenarians in the world, 2.7 times as
large as the next largest sample of centenarians of GWAS on longevity. The CLHLS GWAS includes
5.6million single-nucleotide polymorphisms (SNPs) (0.82million genotyped SNPs and 4.8million
imputed SNPs) for each of the centenarians andmiddle-aged controls (eAppendix section S3.1 in the
Supplement).5 The CLHLS GWAS followed the Strengthening the Reporting of Genetic Association
Studies (STREGA) reporting guideline for GWASquality control,12 including genotyping errors, population
stratification, andHardy-Weinberg equilibrium,with a full quality item score of 12, indicating goodquality
and completeness.5 The Research Ethics Committees of PekingUniversity andDukeUniversity granted
approval for the Protection of Human Subjects for the CLHLS, including collections of questionnaire data
and DNA samples with written informed consent before participation.
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The Chinese with Han ethnicity make up about 93% of the total population in China, with 53
Chinese minority groups making up 7% of the total population. The sample sizes of anyminority
group in the CLHLS data are too small for meaningful analysis, so we included Han Chinese samples
only in the present study.5 Detailed descriptions of the CLHLS phenotype and genotype data sets are
presented in eAppendix sections S2 and S3 in the Supplement.
We adopted a stratification framework of north and south regions of China as discovery and
evaluation samples (eAppendix section S3.2, eTable 1, and eFigures 1-4 in the Supplement), following
most published case-control genetic studies using Chinese nationwide data sets and based on
analyses of principal components, genetics (classic markers, microsatellite DNAmarkers,
mitochondrial DNA, and Y chromosome SNPmarkers), anthropology, and linguistics, reported in the
literature.13
We conducted 2-stage consecutive analyses, with sex-specific GWAS to identify candidate
sex-specific loci and sex-specific pathways in stage 1 and polygenic risk score (PRS) analysis in stage 2
(Figure). To avoid the high false-negative rate and to fully use the available independent GWAS data
sets of north and south regions of China, we applied the bidirectional discovery and evaluation
approach14 (eAppendix section S4 in the Supplement) in our sex-specific GWAS and PRS analyses. A
priori thresholds of P < 10−5, P < 10−4, or P < 10−3 or higher were defined for selecting informative
SNPs in the discovery step of recent GWAS or PRS studies depending on the circumstances of the
research, while P < 5 × 10−8 is the standard for genome-wide significance.15 We aimed to identify
groups of sex-specific SNPs that individually may have very small effects but may jointly have large
effects. Thus, it is reasonable to choose a modest a priori threshold of P < 10−3 and P < .01 in the
discovery step of sex-specific single SNP analysis. We performed sex-specific GWAS using PLINK
(version 1.06).16 Tominimize population stratification effects, we adjusted for the top 2 eigenvectors,
which corrected nearly all of the stratification that can be corrected.17 In the combined north and
south data analysis, we also adjusted for respective north and south regions.
The best-fit P value cutoffs .0042 and .02 (calculated by PRSice software with the BEST_FIT
command18) were used to select SNPs for pathway analyses in men and women, respectively. We
implemented an improved gene set enrichment analysis for GWAS using the i-GSEA4GWAS
database19 to map genes to pathways. Sex-specific pathway gene sets with P < .005 and false
discovery rate (FDR) < 0.05 were regarded as significantly associated with longevity.
Figure. Flowchart of the 2-Stage Consecutive Analyses
North and south bidirectional discovery-evaluation
analysis of male-specific loci and comparison with 
results in women
North and south bidirectional discovery-evaluation 
analysis of female-specific loci and comparison with
results in men  
Logistic regressions including loci, sex, and loci-sex
interaction term, using north-south combined data set
Comparison of sex-specific loci found in CLHLS GWAS
with sex-stratified results from US NECS and European
IDEAL studies
Pathway analysis using the male data set Pathway analysis using the female data set
PRS analysis of male data set using ORs estimated 
based on north (or south) discovery sample to 
construct PRS scores in south (or north) target 
sample, replication analysis, and comparison with
results in women
PRS analysis of female data set using ORs estimated
based on north (or south) discovery sample to 
construct PRS scores in south (or north) target 
sample, replication analysis, and comparison with 
results in men
Logistic regressions including PRS, sex, and PRS-sex
interaction term, using north-south combined data set
St
ag
e 
1:
se
x-
sp
ec
ifi
c 
GW
AS
St
ag
e 
2:
se
x-
sp
ec
ifi
c 
PR
S 
an
al
ys
is Stage 1 was a sex-specific genome-wide association
study (GWAS) that analyzed single-nucleotide
polymorphisms (SNPs) and pathways. Stage 2 was a
sex-specific polygenic risk score (PRS) analysis. CLHLS
indicates Chinese Longitudinal Healthy Longevity
Study; IDEAL, European Union Longevity Genetics
Consortium; NECS, New England Centenarians Study;
OR, odds ratio.
JAMANetworkOpen | Genetics andGenomics Sex Differences in Genetic AssociationsWith Longevity
JAMA Network Open. 2018;1(4):e181670. doi:10.1001/jamanetworkopen.2018.1670 August 24, 2018 3/15
Downloaded From:  by a University Library of Southern Denmark User  on 10/23/2018
We conducted PRS analyses in stage 2 based on 2 considerations. First, each of the candidate
sex-specific loci identified in stage 1 had a very small effect, leading to further assessment of their
joint effects by PRS analyses. Second, the candidate sex-specific loci selected in stage 1 were
individually not significant (P > .05) in the other sex, but their joint effects could be large and
significant in the other sex (eAppendix section S5 in the Supplement); PRS analyses allowed us to
evaluate and filter out those loci that are not truly sex specific.
Using PRSice software18 and standardmethods,20 we constructed PRS scores as the sum of the
number of risk allele copies of each of the selected loci multiplied by the log of the corresponding
odds ratio of longevity, and then divided by the total number of selected loci for each of the
centenarians andmiddle-aged controls. We conducted analysis including a PRS-sex interaction term
based on the continuous PRS. We used the PRSice clumping method to select independent loci by
excluding all SNPs with linkage disequilibrium (r2 > 0.1); only independent loci were used to calculate
the PRS.
Following standard procedures,20 we used the sex-specific odds ratios estimated based on the
discovery sample of north (or south) region as weights to construct the PRS in the target sample of
south (or north) region; we also conducted the PRS analysis on the sex-specific loci that were
replicated across discovery and target samples, using the north-south combined data set.
Results
Analyses of Single SNPs
Results in Table 1 indicate 11 independent male-specific loci (including the SNP rs1950902 in the
MTHFD1 gene) associated with longevity that replicate in themale discovery and evaluation data sets
of north and south regions (with P < 10−3 in the discovery step) and reached P < 10−5 and FDR < 10−4
in the male north-south combined data set, but were not significant (P = .17-.95) in the female
north-south combined data set. The loci-sex interaction effects of these loci were significant
(P = 8.40 × 10−6 to 8.45 × 10−4).
As shown in Table 2, we identified 11 independent female-specific loci (including the SNP
rs1027238 at the FAM19A1 gene and the SNP rs2161877 near TBX3) whose associations with longevity
were replicated in female discovery and evaluation data sets of north and south regions (with
P < 10−3 in the discovery step) and reached P < 10−5 and FDR < 10−4 in the female north-south
combined data set, but were not significant (P = .13-.97) in themale north-south combined data set.
The loci-sex interaction effects of these female-specific loci were significant (P = 2.8 × 10−4 to
2.5 × 10−2).
Following the widely practiced approach in the PRS literature,18,20 in addition to the 11 male-
specific and 11 female-specific loci outlined, we also identified candidate sex-specific loci with a more
relaxed prior threshold for further PRS analyses. With a prior threshold of P < .01 in the discovery
step, we found that additional 47male-specific and 34 female-specific independent loci were
associated with longevity and replicated across north and south samples, had a 10−5  P < 10−4 in
one sex but were not significant in the other sex, and had P < .05 for the loci-sex interaction effects,
using the north-south combined data set. As discussed earlier, the 11 male-specific and 11 female-
specific loci (P < 10−5) and 47male-specific and 34 female-specific loci (10−5  P < 10−4) are
individually candidates of sex-specific longevity loci, and whether their joint effects are truly
sex-specific was investigated in the PRS analyses.
The Chinese sex-specific loci that were significant (P < 10−4) in one sex but not significant
(P > .05) in the other sex and available in the New England Centenarians Study (NECS) and European
Union Longevity Genetics Consortium (IDEAL) were tested for replication in NECS and IDEAL. The
samples and data sources of GWAS on longevity from NECS and IDEAL are described by Sebastiani
et al2 and Deelen et al.3 The results of comparisons across the Chinese CLHLS, the US NECS and
European IDEAL presented inTable 3, show that rs60210535 of LINC00871 replicated betweenChinese
(P = 9.0 × 10−5) and American (P = 4.6 × 10−5) women, but was not significant in both Chinese and
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Americanmen (P = .49-.69). Another female-specific locus, rs2622624 of ABCG2, had P = 6.8 × 10−5
in Chinese women and P = .003 in European women but was not significant in both Chinese and
Europeanmen (P = .08-.59). ABCG2 is a well-known breast cancer resistance protein (BCRP).21
LINC00871 is a noncoding RNA gene, and its function is uncertain.
Sex-Specific PathwayAnalysis
Sex-specific differences were found in the biochemical pathways that influence human longevity.
There are 11 pathways significantly associated with longevity in men (P < .005 and FDR < 0.05)
(eTable 2 in the Supplement). These pathways are enrichedmainly for immune and inflammatory
responses, including immunity (TLR3) pathway, inflammatory cytokines and Toll-like receptor (TLR)
signaling pathways, and the proinflammatory cytokine interleukin 6 (IL-6) pathway. In women, 34
pathways were enriched significantly (P < .005 and FDR < 0.05) and clustered to metabolic
pathways (eTable 3 in the Supplement). The tryptophanmetabolic pathway and the PPARγ
coactivator-1α (PGC-1α) pathway were among the top pathways in this set.
PRSAnalyses to Assess Joint Effects of Groups of Sex-Specific Loci on Longevity
The PRS analyses using the north (or south) data set as the discovery sample and the south (or north)
data set as the target sample showed that sex-specific joint associations with longevity of the 11
male-specific and 11 female-specific loci were replicated across north and south samples. More
specifically, either using the north sample as the discovery and the south sample as the target, or vice
versa, the 11 male-specific and 11 female-specific loci were jointly and significantly associated with
longevity in one sex (P = 7.2 × 10−22 to 4.0 × 10−12) but not jointly associated with longevity in the
other sex (P = .15-.76); the PRS-sex interaction effects were significant (P = 5.6 × 10−20 to 6.5 × 10−8)
(Table 4).
As discussed in eAppendix section S5 in the Supplement, based on the additional 47 male-
specific and 34 female-specific candidate loci outlined earlier, we applied the stepwise approach that
has been used widely in the PRS literature18,20 and we used the PRSice method and software18 to
select an ideal P value cutoff (PT) in the other sex to provide the best-fitting PRS; we further identified
35 north-south individually replicated male-specific loci with P < 10−4 in men but P > .25 in women
and 25 female-specific loci with P < 10−4 in women but P > .35 in men (eTables 4 and 5 in the
Supplement). The results indicate that the sex-specific joint associations with longevity of these 35
male-specific and 25 female-specific loci were replicated across north and south samples; namely,
they were jointly and significantly associated with longevity in one sex (P = 5.4 × 10−35 to 1.8 × 10−26)
but not jointly associated with longevity in the other sex (P = .07-.93), and the PRS-sex interaction
effects were significant (P = 2.2 × 10−16 to 7.2 × 10−30), either using the north sample as the discovery
and the south as the target, or vice versa (Table 4).
Analyses using the north-south combined data set showed that the 11 male-specific and 11
female-specific loci (P < 10−5) and 35male-specific and 25 female-specific loci (10−5  P < 10−4) were
jointly and significantly associated with longevity in one sex (P = 2.9 × 10−70 to 1.3 × 10−39) but not
jointly significant in the other sex (P = .11 to .70); PRS-sex interaction effects were significant
(P = 4.8 × 10−50 to 1.2 × 10−16) (Table 4).
Discussion
Of the 11 male-specific loci associated with longevity, rs1950902 in theMTHFD1 gene is a
nonsynonymous SNP that causes a C-to-T transition at nucleotide 401 resulting in an arginine-to-lysine
substitution at amino acid 134 (C401T;R134K).MTHFD1was found to be associated with a protective
role for colon and liver cancer risks prevalent in men22 and is consistent with the present study that
MTHFD1 is significantly and positively associated with longevity in men (P = 1.09 × 10−7) but not
significant in women (P = .95) (Table 1).
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Among the 11 male-specific loci associated with longevity, the SNP rs1027238 at FAM19A1was
identified as a novel SNP that is significantly associated with longevity in women (P = 2.8 × 10−6) but
not inmen (P = .37). The SNP rs2161877 near TBX3was significantly associatedwith longevity inwomen
(P = 2.9 × 10−6) but not in men (P = .72), which is consistent with previous findings that TBX3 plays
an important role in mammary gland development and breast cancer with a close relationship to
estrogen.23
Clinical data demonstrate that men and women differ regarding their innate, humoral, and cell-
mediated responses to bacterial and viral challenge.24 For example, men develop lower antibody
responses and show significantly lower vaccine efficacy than women. Moreover, it is well known that
longevity is associated with sex-specific differences in the immune system, and that there is a
progressive decline in immunity and dysregulated inflammatory response in men.25,26 Consistent
Table 4. Polygenic Risk Score Analyses on the Joint Effects of Sex-Specific Loci’s AssociationWith Longevity
Analysis
Main Effect of PRS in Men Main Effect of PRS in Women
OR (95% CI) of PRS-Sex
Interaction P Value of
PRS-Sex
Interaction
Pseudo
R2
OR
(95% CI) P Value
OR
(95% CI) P Value Men Women
A. Analyses using north data set as discovery
sample and south data set as target samplea
A1. 11 Male and 11 female loci with P < 10-5b
11 Loci with P < 10-5 in men but P > .05
in women
2.136
(1.73-2.64) 4.0 × 10
-12 1.040
(0.93-1.16) .48
2.054
(1.62-2.61)
0.487
(0.38-0.62) 4.1 × 10
-9 0.025
11 Loci with P < 10-5 in women but P > .05
in men
0.886
(0.75-1.05) .15
1.782
(1.58-2.01) 4.1 × 10
-21 0.497
(0.41-0.61)
2.011
(1.64-2.46) 2.2 × 10
-11 0.040
A2. 35 Male and 25 female loci with
10-5 ≤ P < 10-4c
35 Male-specific loci with 10-5 ≤ P < 10-4
in men but P > .25 in women
3.618
(2.86-4.58)
1.8 × 10-26 1.005
(0.90-1.12)
.92 3.599
(2.77-4.68)
0.278
(0.21-0.36)
8.5 × 10-22 0.066
25 Female-specific loci with
10-5 ≤ P < 10-4 in women but P > .35
in men
0.920
(0.78-1.09)
.33 2.229
(1.96-2.54)
2.5 × 10-34 0.413
(0.33-0.51)
2.423
(1.96-2.99)
2.2 × 10-16 0.069
B. Analyses using south data set as discovery
sample and north data set as target sample
B1. 11 Male and 11 female loci with P < 10-5
11 Loci with P < 10-5 in men but P > .05
in women
2.473
(2.06-2.97) 7.2 × 10
-22 0.935
(0.85-1.03) .17
2.644
(2.15-3.25)
0.378
(0.31-0.46) 5.6 × 10
-20 0.044
11 Loci with P < 10-5 in women but P > .05
in men
0.976
(0.84-1.14) .76
1.626
(1.47-1.80) 1.3 × 10
-20 0.601
(0.50-0.72)
1.665
(1.38-2.00) 6.5 × 10
-8 0.037
B2. 35 Male and 25 female loci with
10-5 ≤ P < 10-4
35 Male-specific loci with 10-5 ≤ P < 10-4
in men but P > .25 in women
3.509
(2.87-4.29)
4.2 × 10-34 0.956
(0.87-1.05)
.36 3.671
(2.93-4.59)
0.272
(0.22-0.34)
7.2 × 10-30 0.072
25 Female-specific loci with
10-5 ≤ P < 10-4 in women but P > .35
in men
0.872
(0.75-1.01)
.07 2.014
(1.80-2.25)
5.4 × 10-35 0.433
(0.36-0.52)
2.31
(1.92-2.78)
6.3 × 10-19 0.062
C. Analyses using north and south combined data
set
C1. 11 Male and 11 female loci with P < 10-5
11 Loci with P < 10-5 in men but P > .05
in women
2.579
(2.24-2.97) 1.3 × 10
-39 1.061
(0.99-1.14) .11
2.431
(2.08-2.84)
0.411
(0.35-0.48) 1.0 × 10
-27 0.043
11 Loci with P < 10-5 in women but P > .05
in men
0.978
(0.88-1.09) .70
1.741
(1.61-1.88) 2.8 × 10
-42 0.562
(0.49-0.64)
1.779
(1.55-2.04) 1.2 × 10
-16 0.040
C2. 35 Male and 25 female loci with
10-5 ≤ P < 10-4
35 Male-specific loci with 10-5 ≤ P < 10-4
in men but P > .25 in women
3.996
(3.40-4.69)
1.5 × 10-64 1.048
(0.97-1.13)
.21 3.812
(3.20-4.55)
0.262
(0.22-0.31)
4.8 × 10-50 0.079
25 Female-specific loci with
10-5 ≤ P < 10-4 in women but P > .35
in men
0.934
(0.84-1.04)
.22 2.141
(1.97-2.33)
2.8 × 10-70 0.436
(0.38-0.50)
2.293
(2.00-2.63)
4.3 × 10-32 0.066
Abbreviations: OR, odds ratio; PRS, polygenic risk score.
a In analyses presented in sections A and B, we used the ORs of the sex-specific loci
estimated based on the discovery sample of north (or south) data set as weights to
construct the PRS scores in the target sample of south (or north) data set, following the
standard procedure applied in the literature.20
b The detailed information of the 11 male-specific and 11 female-specific longevity loci
with P < 10−5 are presented in Tables 1 and 2.
c The detailed information of the 35male-specific and 25 female-specific loci with
10−5 P < 10−4 are presented in eTables 4 and 5 in the Supplement.
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with these trends, and with previous genetics findings,27,28 we found that the proinflammatory
cytokine IL-6 pathway was significantly associated with longevity in men. Furthermore, we found
that the TLR3 signaling pathway was the most significant pathway associated with male longevity.
Others have also reported that the TLR3 signaling pathway is dysregulated in elderly humans.29 TLR3
signaling evokes IL-6 production,30 and it initiates innate immunity and facilitates adaptive immunity
by promotingmaturation of dendritic cells.30,31 It is reasonable to hypothesize that dysregulation of
the IL-6 and TLR3 signaling pathways renders men more susceptible than women to bacterial and
viral infections; conversely, in long-livedmen, altered IL-6 and TLR3 signaling pathways may provide
greater protection against these challenges.32
Our findings regarding the female-specific tryptophanmetabolic pathway reflect the
documented significantly lower tryptophan levels in blood serum in female centenarians compared
with the younger female controls (P < .001), but that the differences were not significant in male
centenarians compared with younger male controls.33 Tryptophanmetabolism contributes to a
number of key processes, ranging from regulating innate and adaptive immunity34 to supporting
intermediary metabolism via the provision of nicotinamide adenine dinucleotide (NAD+) and
nicotinamide adenine dinucleotide phosphate to the biosynthesis of serotonin and related signaling
molecules. PGC-1α is the master regulator of mitochondrial biogenesis and function because it
promotes the expression of many of themore than 1000 nuclear-encodedmitochondrial genes and
also participates in the regulation of innate immunity.35 One product of tryptophanmetabolism,
NAD+, is a cofactor for sirtuins, which have been implicated in inflammation, stress resistance, and
aging. Coincidentally, sirtuin 1 deacetylates PGC-1α and enhances PGC-1α activity.36 Aging is
associated with progressive mitochondrial dysfunction, and while the ultimate cause for this
dysfunction is unknown, insufficient NAD+ availability and sirtuin 1 enzymatic activity may be
contributing factors.36,37
In considering the female andmale longevity-associated pathways together, the potential
involvement of the innate immune system inmen and of the tryptophan and PGC-1 pathways in the
regulation of immune-related pathways in women suggests that women and men have optimized
different approaches for solving the same biological riddle.
The estimates using QUANTO software version 1.1 (USC Biostats) indicate that both our male-
specific GWAS and female-specific GWAS have acceptably good power (eTables 6a-6b in the
Supplement). The estimates using the AVENGEME software38 indicate that power for both of our
male-specific and female-specific PRS analyses is excellent: 0.997 to 0.999 for men and 1.00 for
women (eTable 7 in the Supplement). As discussed in the Methods section, the sex-specific GWAS
(stage 1) provides candidate sex-specific loci, and our conclusions of reconfirmed sex-specific
longevity loci are mainly based on the PRS analyses (stage 2).
Onemay question whether the findings that loci that are significantly associated with longevity
inwomen but not significant inmen (Table 2 and Table 4; eTable 5 in the Supplement) are due to the
substantially smaller sample size of male centenarians compared with female centenarians, which is
common to all studies on longevity involving centenarians. We do not think this is the case because
male centenarians are much more stringently mortality selected than their female counterparts,
given that therewere 2.3male centenarians per 1millionmen comparedwith 7.8 female centenarians
per 1 million women in China in the 1990s,39 and the death rates in menwere significantly higher
than those of women at younger and older ages. Consequently, the P values of loci-sex interaction
effects for male-specific loci (Table 1; eTable 4 in the Supplement) are all substantially smaller (ie,
more significant) than the P values of loci-sex interaction effects for female-specific loci (Table 2;
eTable 5 in the Supplement). These phenomena reflect a function of the greater mortality selection
of survival to ages 100 years and older for the male centenarians than the female centenarians.
Clearly, the male centenarians’ more stringent mortality selectionmay partially offset the shortage of
power due to their much smaller sample size compared with female centenarians.
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Limitations
While our findings are innovative, the present study has some important limitations warranting
further investigation. Unanswered questions include whether the genetic association with longevity
is stronger in women or men and what the sex differences are in the genetic variants that are
positively or negatively associated with longevity. More replications, meta-analyses, functional
validations, and investigations of the effects of interactions between sex-specific genetic variants
and environmental factors on health outcomes remain to be explored. Such further investigations
may substantially contribute to more effective and targeted individualized health care for male and
female elderly populations.
Conclusions
The findings of the present study clearly indicate sex differences in genetic associations with
longevity. Sex-specific associations with longevity of 4 exclusive groups of 11 male-specific and 11
female-specific loci (P < 10−5) and 35male-specific and 25 female-specific loci (P < 10−4) are
individually and jointly replicated across north and south discovery and target samples. Analyses
using the north-south combined data set showed that these 4 groups of sex-specific loci are jointly
and significantly associated with longevity in one sex (P = 2.9 × 10−70 to 1.3 × 10−39), but not jointly
significant in the other sex (P = .11-.70), while interaction effects between PRS and sex are significant
(P = 4.8 × 10−50 to 1.2 × 10−16). Although we recognize the large differences across ethnicities of
different continents, it is noteworthy that 2 sex-specific loci were replicated between Chinese and US
or European populations.We discovered that 11male-specific pathways (inflammation and immunity
genes) and 34 female-specific pathways (tryptophanmetabolism and PGC-1α induced) are
significantly associated with longevity.
As shown in Table 1 and Table 2 and eTables 4 and 5 in the Supplement, if one estimated
regressions using themale-female combined data set adjusted for sex as a covariate without a
loci-sex interaction term as used in all previously published GWAS on longevity,2-5 the P values of all
of the north-south replicated sex-specific longevity loci listed in Table 1 and Table 2 and eTables 4 and
5 in the Supplementwould increase substantially, and theywould all become nonsignificant with the
given suggestive significance level of P < 10−5 or P < 10−4, and 2male-specific longevity loci (P < 10−5)
in Table 1 and 11male-specific longevity loci (P < 10−4) in eTable 4 in the Supplementwould even have
a P > .05. This is because the associations of the sex-specific loci with longevity are substantially
offset by the nonsignificance in the other sex if the male-female combined data set were used while
adjusted for sex as a covariate. As reviewed in the Introduction section, all previously published
GWAS on longevity identified sex-independent genetic variants (such as APOE, 5q33.3, IL6, FOXO1A,
and FOXO3A)2-5,40 but missed sex-specific loci and pathways associated with longevity. This is
consistent with the conclusion that “genetic studies that ignore sex-specific effects in their design
and interpretation could fail to identify a significant proportion of the genes that contribute to risk for
complex diseases.”41 The present study contributes to filling this gap and identifies significant sex
differences in genetic association with longevity.
Numerous studies have demonstrated sex differences in genetic variants’ reactions to the same
nutritional intervention or drug treatment, steering away from the traditional view of one-size-
fits-all health care andmedicine.42-45 The present study provides a scientific basis for further
investigations on sex-specific genetic variants associated with longevity and health to contribute to
individualized health care. For example, the sex-specific loci and pathways significantly associated
with longevity identified in the present study may serve as potential candidates of the sex-specific
genomic biomarkers for in-depth research to be used in effective individualized health promotions
and interventions.
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